InvestorsHub Logo
Followers 290
Posts 11893
Boards Moderated 0
Alias Born 01/24/2012

Re: None

Wednesday, 06/06/2018 6:34:09 PM

Wednesday, June 06, 2018 6:34:09 PM

Post# of 421
Good news for PTI:
https://backend.otcmarkets.com/otcapi/company/sec-filings/12800293/content/html

On June 6, 2018 the Company announced the following information:

Proteostasis Therapeutics, Inc. today announced positive results from the Company’s ongoing 14-day dosing study of PTI-801 in CF patients on background Orkambi ® (lumacaftor/ivacaftor) therapy. The Company believes these results support the goal of studying PTI-801 as part of the Company’s proprietary double and triple combination therapy regimens.